Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2006.02879.x/fullpdf
Reference29 articles.
1. Selected loss of tolerance evidenced by Crohn's disease–associated immune responses to auto- and microbial antigens
2. BACTERIAL INTERACTIONS WITH CELLS OF THE INTESTINAL MUCOSA: TOLL-LIKE RECEPTORS AND NOD2
3. A Comparative Study of Metronidazole and Sulfasalazine for Active Crohn's Disease: The Cooperative Crohn's Disease Study in Sweden
4. Double blind, placebo controlled trial of metronidazole in Crohn's disease.
Cited by 146 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antibiotics for inflammatory bowel disease: Current status;Indian Journal of Gastroenterology;2024-02
2. New insights into the interplay between intestinal flora and bile acids in inflammatory bowel disease;World Journal of Clinical Cases;2022-10-26
3. Role of Bile Acids and Nuclear Receptors in Acupuncture in Improving Crohn’s Disease;Evidence-Based Complementary and Alternative Medicine;2022-05-13
4. Contribution of the Gut Microbiota to Intestinal Fibrosis in Crohn's Disease;Frontiers in Medicine;2022-02-07
5. Microbial Modulation in Inflammatory Bowel Diseases;Immune Network;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3